Annual Drug Patent Expirations for FEMTRACE
Femtrace is a drug marketed by Apil and is included in one NDA. There are three patents protecting this drug.
This drug has eleven patent family members in ten countries.
The generic ingredient in FEMTRACE is estradiol acetate. Additional details are available on the estradiol acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
